Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

邮发代号 80-967

2019 Impact Factor: 3.421

Frontiers of Medicine  2022, Vol. 16 Issue (1): 150-155   https://doi.org/10.1007/s11684-021-0846-5
  本期目录
Novel mutation c.1210-3C>G in cis with a poly-T tract of 5T affects CFTR mRNA splicing in a Chinese patient with cystic fibrosis
Xinyue Zhao1, Keqiang Liu1, Wenshuai Xu2, Meng Xiao1, Qianli Zhang1, Jiaxing Song1, Keqi Chen2, Yaping Liu1(), Xinlun Tian2(), Kai-Feng Xu2, Xue Zhang1
1. McKusick-Zhang Center for Genetic Medicine, State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China
2. Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
 全文: PDF(1174 KB)   HTML
Abstract

Cystic fibrosis (CF) is a rare autosomal recessive disease with only one pathogenic gene cystic fibrosis transmembrane conductance regulator (CFTR). To identify the potential pathogenic mutations in a Chinese patient with CF, we conducted Sanger sequencing on the genomic DNA of the patient and his parents and detected all 27 coding exons of CFTR and their flanking intronic regions. The patient is a compound heterozygote of c.2909G>A, p.Gly970Asp in exon 18 and c.1210-3C>G in cis with a poly-T of 5T (T5) sequence, 3 bp upstream in intron 9. The splicing effect of c.1210-3C>G was verified via minigene assay in vitro, indicating that wild-type plasmid containing c.1210-3C together with T7 sequence produced a normal transcript and partial exon 10-skipping-transcript, whereas mutant plasmid containing c.1210-3G in cis with T5 sequence caused almost all mRNA to skip exon 10. Overall, c.1210-3C>G, the newly identified pathogenic mutation in our patient, in combination with T5 sequence in cis, affects the CFTR gene splicing and produces nearly no normal transcript in vitro. Moreover, this patient carries a p.Gly970Asp mutation, thus confirming the high-frequency of this mutation in Chinese patients with CF.

Key wordscystic fibrosis    CFTR    splicing mutation    minigene
收稿日期: 2020-06-21      出版日期: 2022-03-28
Corresponding Author(s): Yaping Liu,Xinlun Tian   
 引用本文:   
. [J]. Frontiers of Medicine, 2022, 16(1): 150-155.
Xinyue Zhao, Keqiang Liu, Wenshuai Xu, Meng Xiao, Qianli Zhang, Jiaxing Song, Keqi Chen, Yaping Liu, Xinlun Tian, Kai-Feng Xu, Xue Zhang. Novel mutation c.1210-3C>G in cis with a poly-T tract of 5T affects CFTR mRNA splicing in a Chinese patient with cystic fibrosis. Front. Med., 2022, 16(1): 150-155.
 链接本文:  
https://academic.hep.com.cn/fmd/CN/10.1007/s11684-021-0846-5
https://academic.hep.com.cn/fmd/CN/Y2022/V16/I1/150
Fig.1  
Fig.2  
Fig.3  
1 JR Riordan, JM Rommens, B Kerem, N Alon, R Rozmahel, Z Grzelczak, J Zielenski, S Lok, N Plavsic, JL Chou, et al..Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245(4922): 1066–1073
https://doi.org/10.1126/science.2475911 pmid: 2475911
2 M Dorwart, P Thibodeau, P Thomas. Cystic fibrosis: recent structural insights. J Cyst Fibros 2004; 3(Suppl 2): 91–94
https://doi.org/10.1016/j.jcf.2004.05.020 pmid: 15463935
3 B Marshall, A Elbert, K Petren, M Grimes, A Fink, V Myers, A Sewall. Cystic Fibrosis Foundation Patient Registry 2013 Annual Data Report to the Center Directors. Cystic Fibrosis Foundation 2014
4 BJ Rosenstein, GR Cutting. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998; 132(4): 589–595
https://doi.org/10.1016/S0022-3476(98)70344-0 pmid: 9580754
5 A Sahami, R Alibakhshi, K Ghadiri, H Sadeghi. Mutation analysis of exons 10 and 17a of CFTR gene in patients with cystic fibrosis in Kermanshah Province, Western Iran. J Reprod Infertil 2014; 15(1): 49–56
pmid: 24696795
6 SM Moskowitz, JF Chmiel, DL Sternen, E Cheng, RL Gibson, SG Marshall, GR Cutting. Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders. Genet Med 2008; 10(12): 851–868
https://doi.org/10.1097/GIM.0b013e31818e55a2 pmid: 19092437
7 X Tian, Y Liu, J Yang, H Wang, T Liu, W Xu, X Li, Y Zhu, KF Xu, X Zhang. p.G970D is the most frequent CFTR mutation in Chinese patients with cystic fibrosis. Hum Genome Var 2016; 3(1): 15063
https://doi.org/10.1038/hgv.2015.63 pmid: 27081564
8 Y Liu, L Wang, X Tian, KF Xu, W Xu, X Li, C Yue, P Zhang, Y Xiao, X Zhang. Characterization of gene mutations and phenotypes of cystic fibrosis in Chinese patients. Respirology 2015; 20(2): 312–318
https://doi.org/10.1111/resp.12452 pmid: 25580864
9 X Guo, K Liu, Y Liu, Y Situ, X Tian, KF Xu, X Zhang. Clinical and genetic characteristics of cystic fibrosis in Chinese patients: a systemic review of reported cases. Orphanet J Rare Dis 2018; 13(1): 224
https://doi.org/10.1186/s13023-018-0968-2 pmid: 30558651
10 CS Chu, BC Trapnell, S Curristin, GR Cutting, RG Crystal. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 1993; 3(2): 151–156
https://doi.org/10.1038/ng0293-151 pmid: 7684646
11 SJ Delaney, DP Rich, SA Thomson, MR Hargrave, PK Lovelock, MJ Welsh, BJ Wainwright. Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels. Nat Genet 1993; 4(4): 426–430
https://doi.org/10.1038/ng0893-426 pmid: 7691356
12 P Gaildrat, A Killian, A Martins, I Tournier, T Frébourg, M Tosi. Use of splicing reporter minigene assay to evaluate the effect on splicing of unclassified genetic variants. Methods Mol Biol 2010; 653: 249–257
https://doi.org/10.1007/978-1-60761-759-4_15 pmid: 20721748
13 DB Salinas, C Azen, S Young, TG Keens, M Kharrazi, RB Parad. Phenotypes of California CF newborn screen-positive children with CFTR 5T allele by TG repeat length. Genet Test Mol Biomarkers 2016; 20(9): 496–503
https://doi.org/10.1089/gtmb.2016.0102 pmid: 27447098
14 Q Huang, W Ding, MX Wei. Comparative analysis of common CFTR polymorphisms poly-T, TG-repeats and M470V in a healthy Chinese population. World J Gastroenterol 2008; 14(12): 1925–1930
https://doi.org/10.3748/wjg.14.1925 pmid: 18350634
15 F Amato, P Scudieri, I Musante, V Tomati, E Caci, M Comegna, S Maietta, F Manzoni, AM Di Lullo, E De Wachter, E Vanderhelst, V Terlizzi, C Braggion, G Castaldo, LJV Galietta. Two CFTR mutations within codon 970 differently impact on the chloride channel functionality. Hum Mutat 2019; 40(6): 742–748
https://doi.org/10.1002/humu.23741 pmid: 30851139
16 S Kiesewetter, M Macek Jr, C Davis, SM Curristin, CS Chu, C Graham, AE Shrimpton, SM Cashman, LC Tsui, J Mickle, J Amos, WE Highsmith, A Shuber, DR Witt, RG Crystal, GR Cutting. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet 1993; 5(3): 274–278
https://doi.org/10.1038/ng1193-274 pmid: 7506096
17 RA de Nooijer, JM Nobel, HG Arets, AG Bot, FT van Berkhout, YB de Rijke, HR de Jonge, I Bronsveld. Assessment of CFTR function in homozygous R117H-7T subjects. J Cyst Fibros 2011; 10(5): 326–332
https://doi.org/10.1016/j.jcf.2011.03.009 pmid: 21507732
18 S Kimura, Y Okabayashi, K Inushima, Y Yutsudo, M Kasuga. Polymorphism of cystic fibrosis gene in Japanese patients with chronic pancreatitis. Dig Dis Sci 2000; 45(10): 2007–2012
https://doi.org/10.1023/A:1005500210281 pmid: 11117575
19 RJ Gregory, DP Rich, SH Cheng, DW Souza, S Paul, P Manavalan, MP Anderson, MJ Welsh, AE Smith. Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol Cell Biol 1991; 11(8): 3886–3893
https://doi.org/10.1128/MCB.11.8.3886 pmid: 1712898
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed